188 related articles for article (PubMed ID: 17635005)
1. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.
Graubner UB; Porzig S; Jorch N; Kolb R; Wessalowski R; Escherich G; Janka GE
Pediatr Blood Cancer; 2008 Feb; 50(2):259-63. PubMed ID: 17635005
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.
Afzal S; Ethier MC; Dupuis LL; Tang L; Punnett AS; Richardson SE; Allen U; Abla O; Sung L
Pediatr Infect Dis J; 2009 Dec; 28(12):1064-8. PubMed ID: 19773675
[TBL] [Abstract][Full Text] [Related]
3. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
4. Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
Lausen B; Schmiegelow K; Andreassen B; Madsen HO; Garred P
Eur J Haematol; 2006 Jun; 76(6):481-7. PubMed ID: 16494622
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
[TBL] [Abstract][Full Text] [Related]
6. Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*.
van Tilburg CM; Sanders EA; Nibbelke EE; Pieters R; Revesz T; Westers P; Wolfs TF; Bierings MB
Br J Haematol; 2011 Feb; 152(4):433-40. PubMed ID: 21223250
[TBL] [Abstract][Full Text] [Related]
7. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
[TBL] [Abstract][Full Text] [Related]
8. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.
Meir HM; Balawi IA; Meer HM; Nayel H; Al-Mobarak MF
Saudi Med J; 2001 May; 22(5):423-7. PubMed ID: 11376385
[TBL] [Abstract][Full Text] [Related]
9. Infections in childhood acute lymphoblastic leukemia: an analysis of 222 febrile neutropenic episodes.
Bakhshi S; Padmanjali KS; Arya LS
Pediatr Hematol Oncol; 2008 Jun; 25(5):385-92. PubMed ID: 18569840
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
Wang YR; Jin RM; Xu JW; Xiao Y; Zhou DF; Zhang ZQ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
[TBL] [Abstract][Full Text] [Related]
11. [Infectious complications of the treatment of acute lymphoblastic leukemia in children].
Rubie H; Assouline C; Prere MF; Dutour A; Lemozy J; Mouls JL; Gayet-Mengelle C; Robert A
Pediatrie; 1990; 45(5):333-8. PubMed ID: 2165247
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
13. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
14. [Infectious complications in pediatric cancer patients].
Lehrnbecher T; Laws HJ
Klin Padiatr; 2005 Nov; 217 Suppl 1():S3-8. PubMed ID: 16288349
[TBL] [Abstract][Full Text] [Related]
15. The comparison of outcome and cost of three protocols for childhood non-high risk acute lymphoblastic leukemia in China.
Luo XQ; Ke ZY; Guan XQ; Zhang YC; Huang LB; Zhu J
Pediatr Blood Cancer; 2008 Aug; 51(2):204-9. PubMed ID: 18454471
[TBL] [Abstract][Full Text] [Related]
16. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?
Te Poele EM; de Bont ES; Marike Boezen H; Revesz T; Bökkerink JP; Beishuizen A; Nijhuis IJ; Oude Nijhuis CS; Veerman AJ; Kamps WA
Eur J Cancer; 2007 Nov; 43(17):2532-6. PubMed ID: 17702568
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study.
Abbas AA; Fryer CJ; Paltiel C; Chedid F; Felimban SK; Yousef AA; Khattab TM
Pediatr Blood Cancer; 2004 Apr; 42(4):325-31. PubMed ID: 14966828
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]